|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1500 AUD | -14.29% |
|
-14.29% | -16.67% |
| 05-07 | Vectus Biosystems appoints Tara Speranza as CEO | RE |
| 05-07 | Vectus Biosystems Limited Announces the Appointment of Dr Tara Speranza as Its Chief Executive Officer, Effective 7 May 2026 | CI |
| Market Cap | 7.69M 5.38M 4.72M 4.39M 4.03M 7.57M 518M 52.14M 20.37M 254M 20.18M 19.74M 880M | P/E 2024 |
-1.75x | P/E 2025 | -1.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.64M 5.34M 4.69M 4.36M 4M 7.52M 514M 51.79M 20.23M 253M 20.05M 19.61M 874M | EV / Sales 2024 |
2.91x | EV / Sales 2025 | 4.35x |
| Free-Float |
56.81% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% | ||
| 1 week | -14.29% | ||
| Current month | +20.00% | ||
| 1 month | +20.00% | ||
| 3 months | +11.11% | ||
| 6 months | +15.38% | ||
| Current year | -16.67% |
| 1 week | 0.15 |  | 0.18 |
| 1 month | 0.12 | | 0.22 |
| Current year | 0.09 | | 0.22 |
| 1 year | 0.05 | | 0.46 |
| 3 years | 0.04 | | 0.46 |
| 5 years | 0.04 | | 2.2 |
| 10 years | 0.04 | | 2.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tara Speranza
CEO | Chief Executive Officer | - | 2026-05-06 |
Robert Waring
SEC | Corporate Secretary | - | 2015-07-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Maurie Stang
BRD | Director/Board Member | - | 2005-12-11 |
Ronald Shnier
CHM | Chairman | - | 2018-08-30 |
| Director/Board Member | - | 2024-12-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.29% | -14.29% | +150.00% | -65.12% | 6.45M | |
| +1.07% | -3.49% | -3.35% | +11.75% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +647.65% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +60.81% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.31% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +43.00% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.44% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +0.42% | -5.52% | -3.43% | +9.10% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -34.51% | 12.7B | |
| Average | -1.23% | -1.75% | +65.17% | +88.54% | 24.53B | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.42% | +138.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.14M 796K 699K 650K 597K 1.12M 76.68M 7.72M 3.02M 37.7M 2.99M 2.92M 130M | 478K 334K 294K 273K 251K 471K 32.2M 3.24M 1.27M 15.83M 1.26M 1.23M 54.74M |
| Net income | -2.34M -1.64M -1.44M -1.34M -1.23M -2.3M -157M -15.86M -6.2M -77.41M -6.14M -6.01M -268M | -1.78M -1.24M -1.09M -1.02M -932K -1.75M -120M -12.05M -4.71M -58.84M -4.67M -4.57M -203M |
| Net Debt | -780K -545K -479K -446K -409K -768K -52.53M -5.29M -2.07M -25.83M -2.05M -2M -89.29M | -50.99K -35.66K -31.32K -29.12K -26.72K -50.21K -3.43M -346K -135K -1.69M -134K -131K -5.84M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | A$0.1500 | -14.29% | 100,034 |
- Stock Market
- Stocks
- VBS Stock
Select your edition
All financial news and data tailored to specific country editions
